GNGBY

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Getinge AB

CEO
Mattias Perjos
Employees
0
Headquarters

Ekebergsvagen 26
P.O. Box 69
Goeteborg, Vastra Gotalands 305 75
Phone: 46103353000
http://www.getingegroup.com/

News

Health News Roundup: Sarepta slides as FDA about-turn on panel clouds gene therapy approval path; US FDA classifies recall of heart devices by Getinge as most serious and more | Health
Mar 19, 2023 12:59pm

The U.S. Food and Drug Administration planned to hold a meeting of its independent experts to review the gene therapy, the company said late on Thursday, less than a month after saying it would not do so. Amid U.S. pressure on fentanyl, Mexico raises drug lab raids data Mexico''s army has dramatically revised upward the number of drug lab raids it says it conducted under President Andres Manuel Lopez Obrador, according to government data and leaked military documents reviewed by Reuters.


Source:Devdiscourse
US FDA classifies recall of heart devices by Getinge as most serious
Mar 17, 2023 18:43pm

The U.S. Food and Drug Administration (FDA) on Friday classified the recall of Getinge AB''s heart devices as the most serious type, saying their use may cause injuries or death.


Source:Reuters
Vascular Grafts Global Market Report 2023
Feb 08, 2023 15:48pm

Major players in the vascular graft market are B.Braun, C. R. Bard, Cardinal Health, Cook Medical, Endologix, LeMaitre Vascular, Medtronic Plc, Getinge, Terumo Medical Corporation, and Gore Medical. Major players in the vascular graft market are B.Braun, C. R. Bard, Cardinal Health, Cook Medical, Endologix, LeMaitre Vascular, Medtronic Plc, Getinge, Terumo Medical Corporation, and Gore Medical.


Source:GlobeNewswire
Getinge AB (publ) (GNGBF) Q4 2022 Earnings Call Transcript
Feb 01, 2023 17:17pm

Getinge AB (publ) (OTCPK:GNGBF) Q4 2022 Earnings Conference Call February 1, 2023 4:00 AM ETCompany ParticipantsMattias Perjos - President and Chief Executive OfficerLars Sandstrom - Chief…


Source:Seeking Alpha
Getinge AB (publ) 2022 Q4 - Results - Earnings Call Presentation
Feb 01, 2023 09:14am

The following slide deck was published by Getinge AB (publ) in conjunction with their 2022 Q4 earnings call.


Source:Seeking Alpha
FDA classifies Getinge''s heart devices recall as most serious type
Jan 26, 2023 10:26am

The U.S. Food and Drug Administration ((FDA)) classified the recall of Getinge''s (GNGBF) (GNGBY) heart devices as the agency''s Class 1 recall, the most serious type of recall as their…


Source:Seeking Alpha
FDA classifies recall of Getinge''s heart devices as most serious
Jan 25, 2023 18:35pm

https://www.investing.com/news/stock-market-news/fda-classifies-recall-of-getinges-heart-devices-as-most-serious-2988063


Source:Investing.com